Cancer Research Institute Commits Record $34.4 Million to Advance Immunotherapy Amidst Global Funding Uncertainty
In a fiscal year characterized by widespread funding cuts and an increasingly precarious environment for...
Knowledge and News for the Global Fight Against Cancer.
In a fiscal year characterized by widespread funding cuts and an increasingly precarious environment for...
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, transcended the...
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, at the...
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, transcended the...
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held from August 27 to 28, 2026,...
For many individuals navigating a cancer diagnosis, the immediate focus is often on survival and...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg,...
For decades, lung cancer has been inextricably linked to smoking, a perception rooted in overwhelming...
The Cancer Research Institute (CRI) has announced its latest cohort of postdoctoral fellows for the...
The Cancer Research Institute (CRI) has recognized Dr. Aaron Whiteley, an Assistant Professor in the...